ROBERT HERSHBERG

Insider Reports History

Location
Boston, MA
Signature
/s/ Robert Hershberg by Kyle Piskel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROBERT HERSHBERG:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptive Biotechnologies Corp Director Common Stock 46.7K $748K $16.00 10 Dec 2025 Direct
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 73.7K $328K $4.45 18 Jun 2025 Direct
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 40K $109K $2.73 06 Jun 2023 Direct
NanoString Technologies Inc Director Common Stock 10.7K $23.5K $2.19 18 Apr 2022 Direct
HilleVax, Inc. President and CEO, Director Common Stock 0 $0 $2.06 17 Sep 2025 Direct
ATAI Life Sciences N.V. Director Stock Option 103K 05 Nov 2025 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 44K 18 Jun 2025 Direct
Adaptive Biotechnologies Corp Director Stock Option (right to buy) 23.7K 04 Mar 2025 Direct
Silverback Therapeutics, Inc. Director Stock Option (right to buy) 18K 10 Jun 2022 Direct

Insider Reports Filed by ROBERT HERSHBERG

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADPT Adaptive Biotechnologies Corp 10 Dec 2025 1 -$367K 4 Director 12 Dec 2025, 19:11
ATAI Atai Beckley N.V. 05 Nov 2025 4 $0 4 Director 06 Nov 2025, 20:54
ATAI Atai Beckley N.V. 05 Nov 2025 0 $0 3 Director 06 Nov 2025, 20:37
HLVX HilleVax, Inc. 17 Sep 2025 1 $0 4 President and CEO, Director 17 Sep 2025, 16:30
RXRX RECURSION PHARMACEUTICALS, INC. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 17:23
ADPT Adaptive Biotechnologies Corp 12 Mar 2025 1 -$402K 4 Director 12 Mar 2025, 19:48
ADPT Adaptive Biotechnologies Corp 04 Mar 2025 2 $0 4 Director 06 Mar 2025, 19:15
HLVX HilleVax, Inc. 04 Feb 2025 2 -$48.7K 4 President and Chief Executive Officer, Director 12 Feb 2025, 16:05
RXRX RECURSION PHARMACEUTICALS, INC. 03 Jun 2024 2 $0 4 Director 05 Jun 2024, 18:12
ADPT Adaptive Biotechnologies Corp 04 Mar 2024 2 $0 4 Director 06 Mar 2024, 19:45
HLVX HilleVax, Inc. 08 Feb 2024 3 -$173K 4 President and Chief Executive Officer, Director 12 Feb 2024, 19:47
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:20
FATE FATE THERAPEUTICS INC 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:09
ADPT Adaptive Biotechnologies Corp 06 Mar 2023 2 $0 4 Director 08 Mar 2023, 19:06
ADPT Adaptive Biotechnologies Corp 02 Feb 2023 2 $23.9K 4 Director 03 Feb 2023, 16:00
HLVX HilleVax, Inc. 01 Feb 2023 2 $0 4 President and CEO, Director 03 Feb 2023, 15:17
RXRX RECURSION PHARMACEUTICALS, INC. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 20:16
SPRY Silverback Therapeutics, Inc. 10 Jun 2022 1 $0 4 Director 13 Jun 2022, 19:31
FATE FATE THERAPEUTICS INC 09 Jun 2022 2 $0 4 Director 13 Jun 2022, 16:41
FATE FATE THERAPEUTICS INC 03 Jun 2022 1 -$15.3K 4 Director 06 Jun 2022, 16:45
HLVX HilleVax, Inc. 28 Apr 2022 0 $0 3 President and CEO, Director 28 Apr 2022, 21:30
NSTG NanoString Technologies Inc 18 Apr 2022 2 $0 4 Director 18 Apr 2022, 20:27
ADPT Adaptive Biotechnologies Corp 26 Jan 2022 2 $0 4 Director 28 Jan 2022, 18:00
RXRX RECURSION PHARMACEUTICALS, INC. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:45
RXRX RECURSION PHARMACEUTICALS, INC. 01 Oct 2021 1 $0 4 Director 05 Oct 2021, 20:31
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jul 2021 1 $0 4 Director 06 Jul 2021, 17:01
NSTG NanoString Technologies Inc 15 Jun 2021 3 $0 4 Director 17 Jun 2021, 19:00
SPRY Silverback Therapeutics, Inc. 04 Jun 2021 1 $0 4 Director 21 Sep 2021, 17:04
FATE FATE THERAPEUTICS INC 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 17:33